FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells - Wikidata - awgldk - TriplyDB

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells

http://www.wikidata.org/entity/Q35742526

about

Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis miR-223/FBW7 axis regulates doxorubicin sensitivity through epithelial mesenchymal transition in non-small cell lung cancer.Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration.Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.The importance of regulatory ubiquitination in cancer and metastasis.Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.Biliary tract cancer stem cells - translational options and challenges.A short synthetic peptide fragment of human C2ORF40 has therapeutic potential in breast cancer.Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling.MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression.Upregulation of FBXW7 Suppresses Renal Cancer Metastasis and Epithelial Mesenchymal Transition.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.

P2860

Q26765153-0D2D3D41-3DFA-4776-8D45-C3023ADCEF67 Q26771988-892FBA8E-1662-4FC5-BF18-05E8D5F2F6A7 Q26852049-FFCD6149-28D2-4DCE-B935-98E8E3C90059 Q33912870-9AF66739-E2FB-402E-914C-CAC464B8A999 Q37060753-1EFE2CB0-3512-4CE7-9B88-1D4A5B4E5FA0 Q37327751-040A4ABB-7B57-4268-B19F-D2048E4A7F02 Q37457491-9171DF41-AEBE-45C0-BC66-40E052025930 Q37697146-1AECD566-BA8C-4E18-B087-F1126EF6B6A6 Q38262962-BC74650E-20AF-47DC-822F-54C1C49EBC4C Q38716109-3A0E4DB0-1794-4CAF-BCDA-183CC7C45276 Q38740975-31C12265-AE64-4C79-97FD-64C5A22194F0 Q38776694-733DCBA4-07B5-404D-A618-A647DCE546C3 Q39122602-4E7C661B-E429-48C9-8DEC-ADA866B5222D Q39171781-40E49891-CA3D-40FC-B5AC-1C41B7EF7D6E Q39279276-4BCF3CB8-C5F5-4153-AF74-582DEA39C6A9 Q41091827-EF873883-E8DB-4681-AA54-4B203C0EEBB3 Q42334837-0823B3B7-B4EC-45F1-BD9D-29C7B4331295 Q42779463-6EA95BEC-D459-4929-AEA8-484DB631FBF7 Q43956916-19B32B55-FB13-407F-83BC-B9A106026D7F Q47603972-9FFF54E0-A7C2-4941-BEFA-F18D5B307AD9 Q49246389-FF39E3A7-DDE7-4949-872A-C05C24ECDE1C

P2860

FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells

http://www.wikidata.org/entity/Q35742526

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

FBXW7 suppresses epithelial-me ...... al of cholangiocarcinoma cells

@ast

FBXW7 suppresses epithelial-me ...... al of cholangiocarcinoma cells

@en

type

label

FBXW7 suppresses epithelial-me ...... al of cholangiocarcinoma cells

@ast

FBXW7 suppresses epithelial-me ...... al of cholangiocarcinoma cells

@en

prefLabel

FBXW7 suppresses epithelial-me ...... al of cholangiocarcinoma cells

@ast

FBXW7 suppresses epithelial-me ...... al of cholangiocarcinoma cells

@en

P1433

Q35742526-0AD3FEB5-13AB-4649-B924-0A87596BD00D

P1476

Q35742526-3F9D979C-E77C-4277-AF2E-8F077E52E3A4

P2093

Q35742526-0AF0B2E9-FA1C-49B2-8A66-22DFEED5A511

Q35742526-40B8F186-4844-42B1-B17D-E089982845EA

Q35742526-62C085AD-301A-4AD8-8D7E-DB991EC18F69

Q35742526-7D17D02C-7F76-405B-A1B4-192B7760739B

Q35742526-89686199-01C6-42AA-A07D-7F8C7396A411

Q35742526-A8624CFA-E628-49F1-86C1-184D6C5BBE1A

Q35742526-C7BF9FB1-128A-408E-A00C-23C5B94DFF6D

Q35742526-F5F419A0-8485-4990-A703-1DE96821F9E2

P2860

Q35742526-0033F290-9C6A-441B-B494-D7A0CA2E9777

Q35742526-04436614-A90F-4F48-800A-85C5E241CEAC

Q35742526-08F3CF28-55C8-42BC-AD3E-4AC0ECE91E9A

Q35742526-0C358D78-8508-4CBC-A2D6-F0F94ABC5F85

Q35742526-15FCBBF2-B1D9-4FEF-B8A2-0E221584D750

Q35742526-1608A173-43F0-4786-B538-4FF7449480E6

Q35742526-1B683011-175D-4861-9EBD-671064D18AAD

Q35742526-1BAA9EBB-4FAC-4ACE-BFB2-1268ED4AE979

Q35742526-1C66FDFE-3DAA-4DC7-8230-F27D9AE3385A

Q35742526-1DCC0C97-9050-4A83-88AD-90ACE1FECD46

P304

Q35742526-9C2BFC4A-7F6D-4D0E-86CF-7E2AC8FC0406

P31

Q35742526-BB07BBA2-7852-4308-9005-5CD58E5A0781

P356

Q35742526-B8D1AB7A-B346-4E4C-9598-1C7E8462EF5E

P407

Q35742526-C206EFBE-266C-40D9-8218-CCAA4C606D7D

P433

Q35742526-7B494AB7-04C3-4301-B435-41866753881C

P478

Q35742526-11498C61-706D-47D7-BBBF-7C4B0D051D46

P577

Q35742526-0618C82D-EED1-4C33-9FEE-F202FD90953D

P5875

Q35742526-2A564BCB-DE5A-493D-A4D3-469BF6738CEB

P698

Q35742526-7F9698A6-5E9F-41AE-9F5B-179236C151B4

P921

Q35742526-8BA05160-7566-469A-A474-5B08570A3E24

P932

Q35742526-3AD3098A-7E22-4BFA-B6ED-D27EC42D29C9

P356

ONCOTARGET.3355

P1433

P1476

FBXW7 suppresses epithelial-me ...... al of cholangiocarcinoma cells

@en

P2093

Guangwei Wei

http://www.w3.org/2001/XMLSchema#string

Hui Yang

http://www.w3.org/2001/XMLSchema#string

Lili Chen

http://www.w3.org/2001/XMLSchema#string

Xiaofei Lu

http://www.w3.org/2001/XMLSchema#string

Yuli Wang

http://www.w3.org/2001/XMLSchema#string

Yunfei Xu

http://www.w3.org/2001/XMLSchema#string

Yuxin Chen

http://www.w3.org/2001/XMLSchema#string

Ziming Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The epithelial-mesenchymal transition generates cells with properties of stem cells

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

The basics of epithelial-mesenchymal transition

Cholangiocarcinoma

Epithelial-mesenchymal transitions in development and disease

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

The SCF ubiquitin ligase: insights into a molecular machine

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

P304

6310-6325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3355

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273325011

http://www.w3.org/2001/XMLSchema#string

P698

25749036

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

4467439

http://www.w3.org/2001/XMLSchema#string